CD4 and hepatocellular carcinoma: Also, CD28−Tim-3+CD4+ T cells from patients with hepatocellular carcinoma were reported to exhibit impaired ability to produce of IL-2 and IFNγ but their possible exhausted status was not ruled out (43).